InChIKey	LTXREWYXXSTFRX-QGZVFWFLSA-N
Compound Name	Linagliptin
Canonical SMILES	CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	7.53
Source	BindingDB;ChEMBL

DrugBank ID	DB08882
Drug Name	Linagliptin
CAS Number	668270-12-0
Groups	approved investigational
ATC Codes	A10BH05 A10BD19 A10BD11 A10BD27
Description	Linagliptin is a DPP-4 inhibitor developed by Boehringer Ingelheim for the treatment of type II diabetes [L9557]. Linagliptin differs from other DPP-4 inhibitors in that it has a non-linear pharmacokinetic profile, is not primarily eliminated by the renal system, and obeys concentration dependant pr...

---

Categories: Agents causing angioedema Alimentary Tract and Metabolism Blood Glucose Lowering Agents Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (moderate) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates (strength unknown) Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates DPP-IV Inhibitors Drugs Used in Diabetes Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Incretins OCT1 inhibitors OCT2 Inhibitors OCT2 Substrates Oral Hypoglycemics P-glycoprotein inhibitors P-glycoprotein substrates Protease Inhibitors Purines Quinazolines

---

Cross-references: BindingDB: 50228403 ChEBI: 68610 CHEMBL237500 ChemSpider: 8271879 Drugs Product Database (DPD): 20882 D09566 PDB: 356 PubChem:10096344 PubChem:175427132 RxCUI: 1100699 Wikipedia: Linagliptin ZINC: ZINC000003820029